AzTrials
AzTrials

DepressionNCT06252909

Treating Common Mental Disorders in Women in Mozambique by Addressing Intimate Partner Violence in Couples

A study testing Interpersonal Psychotherapy for Couples and Interpersonal Psychotherapy (Individual) in people with Depression and Anxiety, run by New York State Psychiatric Institute.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Adapting mental health treatments to address modifiable interpersonal problems has the potential to improve and sustain outcomes in low-resource settings where treatment gaps persist. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Depression, Anxiety, PTSD
What is being tested?
Interpersonal Psychotherapy for Couples and Interpersonal Psychotherapy (Individual)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
108 participants
Where
No sites listed yet
Study dates
1 May 2025to 30 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Both partners aged ≥18;
  • both partners identify each other as one of (in case of polygamous marriage) their primary sexual partners of the opposite sex;
  • partnered for at least 3 months;
  • woman screens positive for a CMD using the Mental Wellness Tool developed and validated by our PRIDE team in Mozambique;
  • couples have mild to moderate forms of situational IPV (Ongoing Abuse Scale score = 1 or above). See below exclusion criteria for how severity will be determined.;
  • both partners desire to maintain the relationship;
  • woman identifies marital dispute as the main interpersonal problem area causing CMD symptoms.

Who cannot join

  • Any indicators of severe IPV. The determination of severity will be assessed using items (presence or absence) on the Conflict Tactics Scale (CTS). If any couple member answers yes to both of the following items: "I punched or hit my partner with something that could hurt" and "I kicked my partner," couples will be excluded. Couple members who answer yes to any of the following items: "I used a knife or gun on my partner," "I choked my partner," "I slammed my partner against a wall," "I beat up my partner," "I burned or scalded my partner on purpose," will be excluded. Finally, if any couple member reports that a violent behavior was repeated at least six times in a year by their partner or themselves, violence will be considered severe.;
  • (2) discrepancy (>2) in reporting of frequency of violence on CTS in overall average scores of the partners or for any single behavior in the scale. For example, if the female partner reports that her male partner slapped her three times, but the male partner reports that he never slapped his female partner, the couple will be excluded for discrepant reporting for the act of slapping.;
  • history of violent legal offences;
  • male partner has severe CMD symptoms (PHQ-9 score of 20 or above; GAD-7 score of 15 or above; and PCL-C score of 45 or above); and either partner demonstrates/reports
  • serious mental illness,
  • cognitive impairment,
Show all 12Show fewer
  • history of mania (Psychosis Screening Questionnaire score = 1),
  • hazardous alcohol use (AUDIT score of 8 or above),
  • current suicidality,
  • not speaking Portuguese,
  • feeling unsafe to participate,
  • inability to complete the study.

Trial locations and contacts

No sites are listed yet.

About this study

Adapting mental health treatments to address modifiable interpersonal problems has the potential to improve and sustain outcomes in low-resource settings where treatment gaps persist. This K23 Award will prepare the candidate to become an independent investigator with high-impact public health research and expertise in couple-based interventions that address interrelated mental health problems and intimate partner violence in couples by gaining expertise in engagement and treatment of men, adapting an evidence-based treatment for common mental disorders to address IPV in couples, designing and conducting randomized controlled trials with couples, and professional skills development. This work has applicability for low-resource low-income countries and US populations that experience couple-based violence and the mental health treatment gap. With its focus on intimate partners, the intervention also has the potential to benefit health and wellbeing of children.

Being tested
Interpersonal Psychotherapy for Couples, Interpersonal Psychotherapy (Individual)
Medical subject headings
Depression, Anxiety Disorders, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interpersonal Psychotherapy for CouplesBehavioural

    Interpersonal Psychotherapy for Couples (IPT-C) consists of 8 weekly conjoint sessions. The clinical goals are to "promote resolution of the role dispute via renegotiation of role relations between the marriage partners" and improve common mental disorders in the woman. Like Interpersonal Psychotherapy, IPT-C has an initiation phase (Session 1-2), middle phase (Sessions 3-6), and termination phase (Sessions 7-8).

  • Interpersonal Psychotherapy (Individual)Behavioural

    Interpersonal Psychotherapy (IPT) is an evidence-based treatment to reduce depression and other common mental disorders. It focuses on helping patients resolve interpersonal problems of disagreements, loneliness, life changes, and grief, and/or change their orientation to the problem.

Study groups in NCT06252909
Study groupRoleWhat they receive
Interpersonal Psychotherapy for CouplesExperimentalNot described
Receives: Behavioral: Interpersonal Psychotherapy for Couples
Interpersonal Psychotherapy (Individual)Active comparatorNot described
Receives: Behavioral: Interpersonal Psychotherapy (Individual)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Client Satisfaction Questionnaire Client Satisfaction Questionnaire - 8 (CSQ-8)

    The Client Satisfaction Questionnaire - 8 measures respondents' opinions about services they have received. Responses are based on a four-point scale (ranging from very negative to very positive), but the options differ depending on the item. Scores range from 8 to 32; higher values indicate higher satisfaction. Scores are calculated by summing scores across all items.

    Measured: measured at week 8

  2. IPT Fidelity Checklist

    The IPT Fidelity Checklist measures provider fidelity to Interpersonal Therapy. Providers are assessed for low (1), moderate (2), or high (3) adherence to each treatment element. A total score is calculated y summing individuals items. The PRIDE team has adapted this Checklist for Interpersonal Counseling, which will be further adapted in the proposed study for couple-based treatment.

    Measured: measured up to 8 weeks

  3. Mental Wellness Tool

    The Mental Wellness Tool was developed and validated by the PRIDE team in Mozambique to screen for and differentiate cases according to presence or absence of common mental disorders, severe mental illness, substance use disorders, and suicidal risk. Patients are asked three initial questions. If they respond positively to any of the 3 items, they are asked 10 additional items. The Mental Wellness Tool will be used to screen patients for common mental disorders and exclude patients with severe mental illness, substance use disorders, or suicidality. It will additionally be used to track metrics to determine Reach (i.e., number in need).

    Measured: measured at pre-treatment and weeks 8, 12, 20, 32

Secondary outcomes (6)
  1. Patient Health Questionnaire - 9 (PHQ-9)

    The PHQ-9 is an instrument for screening, diagnosing, monitoring, and measuring severity of depression. Score cut offs for depression are 5 (mild), 10 (moderate), 15 (moderately severe) and 20 (severe).

    Measured: measured at pre-treatment and weeks 8, 12, 20, 32

  2. Generalized Anxiety Disorder - 7 (GAD-7)

    GAD-7 is a screening instrument with seven items to assess presence and severity of generalized anxiety severity. Scores range from 0 (not at all) to 3 (nearly every day) for a total range of 0 to 21. Score cut off points are 5 (mild), 10 (moderate), 15 (severe) anxiety.

    Measured: measured at pre-treatment and weeks 8, 12, 20, 32

  3. PTSD Checklist - Civilian Version (PCL-C)

    The PCL-C is a standardized self-report scale for PTSD comprised of 17 items. It uses a 5-point scale where respondents indicate how much they have been bothered by a symptom (1 = Not at All

    • 5 = Extremely). Items are totaled for a severity score (range = 17-85; 17-29 = little to no severity; 30-44 = moderate to moderately high severity; 45-85 = high severity).

    Measured: measured at pre-treatment and weeks 8, 12, 20, 32

  4. Revised Conflict Tactics Scale

    The Revised Conflict Tactics Scale measures physical, psychological, and sexual intimate partner violence. It consists of 39 items are asked twice: once for respondent and once for partner. Item responses gauge frequency and range from "Never" to "20 or more times." It has five subscales: Negotiation, Psychological Aggression, Physical Assault, Injury, and Sexual Coercion.

    Measured: measured at pre-treatment and weeks 8, 12, 20, 32

  5. Dyadic Adjustment Scale

    The Dyadic Adjustment Scale (32 Likert items) measures relationship functioning and satisfaction. The four subscales include: Dyadic Satisfaction, Dyadic Consensus, Dyadic Cohesion, and Dyadic Affectional Expression. The score range is 1-151. A higher score indicates better adjustment to marriage.

    Measured: measured at pre-treatment and weeks 8, 12, 20, 32

  6. Alcohol Use Disorders Identification Test (AUDIT)

    The AUDIT is comprised of 10 items that screen for hazardous or dependent drinking levels. Questions range from 0 to 4 with the exception of items 9 and 10 which have three response options and are scored 0, 2, 4. Items are summed. Score cut off points are 8 (hazardous drinking) and 13 women/15 men (alcohol dependence).

    Measured: measured at pre-treatment and weeks 8, 12, 20, 32

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2024
  2. Study start1 May 2025 (estimated)
  3. Primary completion15 Sep 2025 (estimated)
  4. Study completion30 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
108 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06252909
Sponsor's protocol ID
K23MH122661
Status last verified
May 2024
First submitted
24 Jan 2024
Last updated
20 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Interpersonal Psychotherapy for Couples and Interpersonal Psychotherapy (Individual) in people with Depression and Anxiety, run by New York State Psychiatric Institute.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jennifer Mootz (6467746409, jennifer.mootz@nyspi.columbia.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Client Satisfaction Questionnaire Client Satisfaction Questionnaire - 8 (CSQ-8) (time frame: measured at week 8). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in